Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $3 Million Public Offering of Common Stock of Cocrystal Pharma, Inc.
Press Release – New York, NY – November 4, 2019 – Sichenzia Ross Ference LLP announced today that it has represented Aegis Capital Corp. as sole book runner in the underwritten public offering of 3,529,412 shares of Cocrystal Pharma, Inc. (NASDAQ: COCP) common stock, at a price of $0.85 per share for gross proceeds of approximately $3.0 million. Cocrystal is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics.
The Sichenzia Ross Ference LLP team was led by partners Gregory Sichenzia, Darrin Ocasio and Avital Perlman, counsel Jeff Cahlon and associate Grant Levine.
- Sichenzia Ross Ference LLP Represents Borqs Technologies, Inc. in $27 Million Private Placement - September 23, 2021
- Sichenzia Ross Ference LLP Represents Aegis Capital Corp in $15 Million Registered Direct Offering of Molecular Data Inc. - September 22, 2021
- Sichenzia Ross Ference LLP Represents EzFill in $28.75 Million Initial Public Offering and NASDAQ Listing - September 20, 2021